BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 23891156)

  • 1. Isolation and characterization of interferon lambda-resistant hepatitis C virus replicon cell lines.
    Friborg J; Lin B; Chen C; McPhee F
    Virology; 2013 Sep; 444(1-2):384-93. PubMed ID: 23891156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced expression of Jak-1 and Tyk-2 proteins leads to interferon resistance in hepatitis C virus replicon.
    Hazari S; Taylor L; Haque S; Garry RF; Florman S; Luftig R; Regenstein F; Dash S
    Virol J; 2007 Sep; 4():89. PubMed ID: 17877826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-λ Inhibits MiR-122 Transcription through a Stat3-HNF4α Inflammatory Feedback Loop in an IFN-α Resistant HCV Cell Culture System.
    Aboulnasr F; Hazari S; Nayak S; Chandra PK; Panigrahi R; Ferraris P; Chava S; Kurt R; Song K; Dash A; Balart LA; Garry RF; Wu T; Dash S
    PLoS One; 2015; 10(12):e0141655. PubMed ID: 26657215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ethanol on innate antiviral pathways and HCV replication in human liver cells.
    Plumlee CR; Lazaro CA; Fausto N; Polyak SJ
    Virol J; 2005 Dec; 2():89. PubMed ID: 16324217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel type I interferon IL-28A suppresses hepatitis C viral RNA replication.
    Zhu H; Butera M; Nelson DR; Liu C
    Virol J; 2005 Sep; 2():80. PubMed ID: 16146571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type III Interferon Induces Distinct SOCS1 Expression Pattern that Contributes to Delayed but Prolonged Activation of Jak/STAT Signaling Pathway: Implications for Treatment Non-Response in HCV Patients.
    Liu B; Chen S; Guan Y; Chen L
    PLoS One; 2015; 10(7):e0133800. PubMed ID: 26193702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired antiviral activity of interferon alpha against hepatitis C virus 2a in Huh-7 cells with a defective Jak-Stat pathway.
    Hazari S; Chandra PK; Poat B; Datta S; Garry RF; Foster TP; Kousoulas G; Wakita T; Dash S
    Virol J; 2010 Feb; 7():36. PubMed ID: 20149251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferons alpha and lambda inhibit hepatitis C virus replication with distinct signal transduction and gene regulation kinetics.
    Marcello T; Grakoui A; Barba-Spaeth G; Machlin ES; Kotenko SV; MacDonald MR; Rice CM
    Gastroenterology; 2006 Dec; 131(6):1887-98. PubMed ID: 17087946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of HCV in quiescent hepatic cells under conditions of an interferon-induced antiviral response.
    Bauhofer O; Ruggieri A; Schmid B; Schirmacher P; Bartenschlager R
    Gastroenterology; 2012 Aug; 143(2):429-38.e8. PubMed ID: 22522091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanism of HCV's resistance to IFN-α in cell culture involves expression of functional IFN-α receptor 1.
    Datta S; Hazari S; Chandra PK; Samara M; Poat B; Gunduz F; Wimley WC; Hauser H; Koster M; Lamaze C; Balart LA; Garry RF; Dash S
    Virol J; 2011 Jul; 8():351. PubMed ID: 21756311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatitis C virus replication in mouse cells is restricted by IFN-dependent and -independent mechanisms.
    Nandakumar R; Finsterbusch K; Lipps C; Neumann B; Grashoff M; Nair S; Hochnadel I; Lienenklaus S; Wappler I; Steinmann E; Hauser H; Pietschmann T; Kröger A
    Gastroenterology; 2013 Dec; 145(6):1414-23.e1. PubMed ID: 23973921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct and overlapping genomic profiles and antiviral effects of Interferon-λ and -α on HCV-infected and noninfected hepatoma cells.
    Kohli A; Zhang X; Yang J; Russell RS; Donnelly RP; Sheikh F; Sherman A; Young H; Imamichi T; Lempicki RA; Masur H; Kottilil S
    J Viral Hepat; 2012 Dec; 19(12):843-53. PubMed ID: 23121362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective Jak-Stat activation in hepatoma cells is associated with hepatitis C viral IFN-alpha resistance.
    Zhu H; Nelson DR; Crawford JM; Liu C
    J Interferon Cytokine Res; 2005 Sep; 25(9):528-39. PubMed ID: 16181053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of calcineurin inhibitors, tacrolimus and cyclosporin a, on interferon-induced antiviral protein in human hepatocyte cells.
    Hirano K; Ichikawa T; Nakao K; Matsumoto A; Miyaaki H; Shibata H; Eguchi S; Takatsuki M; Ikeda M; Yamasaki H; Kato N; Kanematsu T; Ishii N; Eguchi K
    Liver Transpl; 2008 Mar; 14(3):292-8. PubMed ID: 18306331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alcohol attenuates anti-HCV function of IFN-λ1 through up-regulation of PLASy expression in human hepatic cells.
    Ran M; Huang J; Liang H; Jiang J; Liang B; Ning C; Zang N; Liao W; Liu H; Qin F; Yang Q; Ho W; Ye L; Chen H
    J Med Virol; 2018 Jun; 90(6):1112-1120. PubMed ID: 29446489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HCV structural proteins interfere with interferon-alpha Jak/STAT signalling pathway.
    Luquin E; Larrea E; Civeira MP; Prieto J; Aldabe R
    Antiviral Res; 2007 Nov; 76(2):194-7. PubMed ID: 17675168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chaperone-Mediated Autophagy Targets IFNAR1 for Lysosomal Degradation in Free Fatty Acid Treated HCV Cell Culture.
    Kurt R; Chandra PK; Aboulnasr F; Panigrahi R; Ferraris P; Aydin Y; Reiss K; Wu T; Balart LA; Dash S
    PLoS One; 2015; 10(5):e0125962. PubMed ID: 25961570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel alpha interferon (IFN-alpha) variant with improved inhibitory activity against hepatitis C virus genotype 1 replication compared to IFN-alpha2b therapy in a subgenomic replicon system.
    Escuret V; Martin A; Durantel D; Parent R; Hantz O; Trépo C; Menguy T; Bottius E; Dardy J; Maral J; Escary JL; Zoulim F
    Antimicrob Agents Chemother; 2006 Dec; 50(12):3984-91. PubMed ID: 17030563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.
    Mukherjee A; Di Bisceglie AM; Ray RB
    J Virol; 2015 Mar; 89(6):3356-65. PubMed ID: 25589644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-28B (IFN-λ3) and IFN-α synergistically inhibit HCV replication.
    Shindo H; Maekawa S; Komase K; Miura M; Kadokura M; Sueki R; Komatsu N; Shindo K; Amemiya F; Nakayama Y; Inoue T; Sakamoto M; Yamashita A; Moriishi K; Enomoto N
    J Viral Hepat; 2013 Apr; 20(4):281-9. PubMed ID: 23490373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.